Opportunity Information: Apply for RFA OD 23 005
The NIH Research Evaluation and Commercialization Hubs (REACH) Awards funding opportunity (RFA-OD-23-005) is a renewed NIH program designed to speed up the movement of academic biomedical discoveries out of the lab and toward real-world products that improve patient care and public health. The central idea is to fund institutions to build or strengthen “Hubs” for academic entrepreneurship. These Hubs are expected to act as organized launchpads that help researchers take promising early-stage technologies and push them through the risky, under-resourced proof-of-concept phase where many innovations typically stall.
This opportunity uses a cooperative agreement mechanism (U01, clinical trial optional), which generally means NIH expects to be actively involved during the award in a collaborative role rather than functioning only as a passive funder. The Hub is not just a single project; it is meant to be an institutional capability that can repeatedly identify, evaluate, and advance multiple technologies. NIH’s intent is that funded Hubs will work together as a consortium, sharing approaches and building a broader national infrastructure for academic translation and commercialization.
The core functions expected of a REACH Hub include building a reliable pipeline for identifying the most promising technologies within NIH’s mission areas, then providing targeted seed funding to individual research teams for “product definition” work. That product definition support can include feasibility studies, prototype development, and proof-of-concept studies that reduce technical and translational uncertainty. Alongside funding, the Hub must supply practical expertise and hands-on support across the areas that typically determine whether a biomedical product can realistically reach the market or the clinic. The FOA specifically highlights scientific and technical guidance, regulatory strategy, reimbursement considerations, business development, legal support (often including IP and contracting), and project management. Another major expectation is workforce and skills development in entrepreneurship, meaning the Hub should help researchers learn how to think and operate more like product developers and founders, not only like investigators.
Public-private partnerships are emphasized as a key success factor. NIH signals that Hubs should not rely solely on federal dollars, but should also bring in additional non-federal support and partnerships that can expand capacity, add specialized expertise, and create smoother pathways to downstream investment or adoption. In practice, this points toward relationships with industry partners, venture groups, accelerators, foundations, health systems, payers, and other stakeholders who can help de-risk technologies and position them for commercialization.
Eligibility is broad across U.S.-based entities and includes state, county, and local governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; federally recognized tribal governments; other tribal organizations; public and private institutions of higher education; nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, HBCUs, tribally controlled colleges and universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments other than federally recognized, and U.S. territories or possessions. At the same time, it clearly restricts foreign involvement: non-U.S. entities (foreign organizations and foreign institutions) cannot apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
Key administrative details provided include the sponsoring agency (National Institutes of Health), the opportunity category (discretionary), the activity category (health), and the CFDA number listed as 93.859. The original closing date shown is February 9, 2023. The award ceiling listed is $1,000,000. The description also notes “ExpectedAwards:” but does not provide a number in the source text provided, so the exact count of anticipated awards is not specified here.Apply for RFA OD 23 005
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
- This funding opportunity was created on 2022-12-02.
- Applicants must submit their applications by 2023-02-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs - NIH Research Evaluation and Commercialization Hubs (REACH) Awards (RFA-OD-23-005)
What is the NIH REACH Awards funding opportunity (RFA-OD-23-005)?
The NIH Research Evaluation and Commercialization Hubs (REACH) Awards program is a renewed NIH initiative designed to speed the movement of academic biomedical discoveries out of the lab and toward real-world products that improve patient care and public health. It focuses on building or strengthening institutional "Hubs" that can repeatedly identify, evaluate, and advance multiple early-stage technologies.
What is the main goal of a REACH Hub?
A REACH Hub is intended to function as an organized launchpad for academic entrepreneurship. Its central mission is to help promising early-stage biomedical technologies get through the high-risk, under-resourced proof-of-concept phase where many innovations typically stall, increasing their chances of reaching commercialization or clinical adoption.
Is the award meant to fund a single research project?
No. The Hub is not described as a single project. It is meant to be an institutional capability that can repeatedly source, evaluate, and advance multiple technologies over time, including providing targeted seed funding and hands-on support to individual teams for product-focused work.
What funding mechanism does this opportunity use?
This opportunity uses a cooperative agreement mechanism (U01), with clinical trial optional. A cooperative agreement generally indicates that NIH expects to play an active, collaborative role during the award period rather than acting only as a passive funder.
What does "clinical trial optional" mean for this FOA?
The funding opportunity states "clinical trial optional," meaning the mechanism allows for projects that may or may not include a clinical trial component. The provided information does not add further constraints or requirements beyond that statement.
What are the core functions NIH expects a REACH Hub to perform?
Based on the description provided, core Hub functions include (1) building a reliable pipeline to identify the most promising technologies within NIH mission areas, (2) providing targeted seed funding to research teams for "product definition" work, and (3) delivering practical expertise and hands-on support across key commercialization and translation areas.
What is meant by "product definition" support?
"Product definition" support refers to activities that help reduce technical and translational uncertainty for early-stage technologies. The FOA examples include feasibility studies, prototype development, and proof-of-concept studies aimed at de-risking an innovation so it can move toward real-world use.
What types of expertise and support should a REACH Hub provide?
The FOA highlights that a Hub should provide scientific and technical guidance, regulatory strategy support, reimbursement considerations, business development assistance, legal support (often including intellectual property and contracting), and strong project management to help teams execute commercialization-oriented milestones.
Is entrepreneurship and workforce development part of the expectation?
Yes. A major expectation is workforce and skills development in entrepreneurship. The Hub is expected to help researchers build practical skills so they can think and operate more like product developers and founders, not only like investigators.
Are public-private partnerships required or encouraged?
Public-private partnerships are emphasized as a key success factor. NIH signals that Hubs should not rely only on federal dollars and should bring in additional non-federal support and partnerships to expand capacity, add specialized expertise, and create smoother pathways to downstream investment or adoption.
What kinds of partners are suggested for non-federal support?
The description points toward relationships with industry partners, venture groups, accelerators, foundations, health systems, payers, and other stakeholders who can help de-risk technologies and better position them for commercialization.
Who is the sponsoring agency?
The sponsoring agency listed is the National Institutes of Health (NIH).
What is the opportunity category and activity category?
The opportunity category is listed as discretionary, and the activity category is health.
What CFDA number is associated with this opportunity?
The CFDA number provided is 93.859.
What is the award ceiling?
The award ceiling listed in the provided information is $1,000,000.
How many awards does NIH expect to make?
The provided description notes "ExpectedAwards:" but does not include a number. Based on the information provided here, the exact count of anticipated awards is not specified.
What is the closing date shown for this opportunity?
The original closing date shown is February 9, 2023.
Who is eligible to apply?
Eligibility is broad across U.S.-based entities. The listed eligible applicants include state, county, and local governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; federally recognized tribal governments; other tribal organizations; public and private institutions of higher education; nonprofits with or without 501(c)(3) status (excluding institutions of higher education under those nonprofit categories); for-profit organizations (other than small businesses); and small businesses.
Are any additional applicant types explicitly called out as eligible?
Yes. The FOA explicitly calls out additional eligible categories including Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, HBCUs, tribally controlled colleges and universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments other than federally recognized, and U.S. territories or possessions.
Are foreign organizations allowed to apply?
No. The opportunity clearly restricts foreign involvement. Non-U.S. entities (foreign organizations and foreign institutions) cannot apply.
Can a U.S. organization include a non-U.S. component or foreign component?
No. The information provided states that non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
Does NIH expect funded Hubs to coordinate with each other?
Yes. NIH's intent is that funded Hubs will work together as a consortium, sharing approaches and building a broader national infrastructure for academic translation and commercialization.
What is the overall problem this program is trying to address?
The program targets the "proof-of-concept" gap, described as a risky and often under-resourced stage where promising academic innovations commonly stall before they are sufficiently de-risked to attract investment, licensing interest, or adoption into real-world patient care and public health settings.
What kinds of technologies is the Hub expected to focus on?
The Hub is expected to identify the most promising technologies within NIH mission areas. The provided description does not further specify particular disease areas or technology categories beyond the scope of biomedical discoveries and products.
Browse more opportunities from the same category: Health
Next opportunity: FY2022 Historic Preservation Fund - Paul Bruhn Historic Revitalization Subgrant Program
Previous opportunity: Small Business Innovation Research and Small Business Technology Transfer Programs Phase I
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA OD 23 005
Applicants also applied for:
Applicants who have applied for this opportunity (RFA OD 23 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R61/R33 Clinical Trial Required) Apply for PAR 23 043 Funding Number: PAR 23 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional) Apply for RFA AT 23 008 Funding Number: RFA AT 23 008 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Interorgan Communication in Aging (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 005 Funding Number: RFA AG 24 005 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional) Apply for PAR 23 050 Funding Number: PAR 23 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed) Apply for RFA AI 22 075 Funding Number: RFA AI 22 075 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NIH StrokeNet- Regional Coordinating Stroke Centers for year 2023 (U24 - Clinical Trials Not Allowed) Apply for RFA NS 23 010 Funding Number: RFA NS 23 010 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| NIH StrokeNet National Coordinating Center for year 2023 (U01 Clinical Trials Not Allowed) Apply for RFA NS 23 009 Funding Number: RFA NS 23 009 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| NIH StrokeNet National Data Management Center for year 2023 (U01 Clinical Trials Not Allowed) Apply for RFA NS 23 008 Funding Number: RFA NS 23 008 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional) Apply for RFA AT 23 009 Funding Number: RFA AT 23 009 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) Apply for PAR 23 063 Funding Number: PAR 23 063 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 23 045 Funding Number: PAR 23 045 Agency: National Institutes of Health Category: Health Funding Amount: $8,000,000 |
| Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed) Apply for RFA AI 22 070 Funding Number: RFA AI 22 070 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required) Apply for RFA AI 22 071 Funding Number: RFA AI 22 071 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| AHRQ and PCORI Learning Health System Embedded Scientist Training and Research Centers (P30) Apply for RFA HS 23 001 Funding Number: RFA HS 23 001 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) Apply for PAR 23 083 Funding Number: PAR 23 083 Agency: National Institutes of Health Category: Health Funding Amount: $325,000 |
| Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) Apply for PAR 23 081 Funding Number: PAR 23 081 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed) Apply for RFA AG 24 024 Funding Number: RFA AG 24 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Brain Tissue Resource Center for Alcohol Research (R28 Clinical Trial Not Allowed) Apply for PAR 23 068 Funding Number: PAR 23 068 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (P30 - Clinical Trial Not Allowed) Apply for RFA AR 24 002 Funding Number: RFA AR 24 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed) Apply for RFA AR 24 001 Funding Number: RFA AR 24 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 23 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
